GleamWall
中文EN

ABCL AbCellera Biologics Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1703057 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY92.1%
TTM net income YoY13.6%
TTM EPS YoY15.8%
Revenue 3-yr CAGR10.4%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-298.0%
Net margin-218.5%
FCF margin-48.4%
EBITDA margin-264.0%

Returns

ROE-14.6%
ROA-10.4%
ROIC (approx.)-18.2%
Asset turnover0.05x

Leverage & solvency

Liabilities / assets29.2%
Debt / equity0.00x
Current ratio12.43x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.10x
Accruals ratio-9.3%
Payout ratio—
Capex / revenue25.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$75.13M$28.83M
R&D expense$186.83M$167.26M
SG&A expense$83.23M$85.49M
Operating income-$217.10M-$314.77M
Pretax income-$177.59M-$200.40M
Income tax-$31.18M-$37.54M
Net income-$146.41M-$162.86M
EBITDA-$198.66M-$302.23M
EPS (basic)-0.49-0.55
EPS (diluted)-0.49-0.55
Weighted avg. shares (diluted)298.71M294.33M
Balance sheet
Cash & equivalents$128.51M$156.32M
Receivables$39.41M$31.98M
Inventory$6.34M$0
Current assets$728.23M$751.37M
Goodwill$47.81M$47.81M
Intangibles$38.38M$42.11M
Total assets$1.36B$1.36B
Current liabilities$64.31M$76.61M
Total liabilities$390.05M$304.47M
Shareholders' equity$966.90M$1.06B
Shares outstanding300.60M295.76M
Cash flow statement
Operating cash flow-$131.29M-$108.56M
Capital expenditure$42.77M$78.40M
Free cash flow-$174.07M-$186.95M
Investing cash flow$87.75M$121.41M
Financing cash flow$14.08M$12.77M
Depreciation & amortization$18.44M$12.54M
Stock-based compensation$55.79M$67.58M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.